[Factor XIIa-inhibited diluted thromboplastin time can reflect coagulation process].
OBJECTIVE
To establish a screening test that can reflect two stages of coagulation process.


METHODS
With FXII a being blocked, the effects of various dilution of thromboplastin on clotting time were observed. FX a activity was determined by chromogenic assay.


RESULTS
(1) At high concentration of thromboplastin, FXII a-inhibited diluted thromboplastin time (FXII ai DTT) of pooled normal plasma and FXI deficient plasma was very similar, but at low concentration, FXII ai DTT was in order of FVIII and FIX deficient plasma > FXI deficient plasma > pooled normal plasma. (2) FXI consumption by immunologic method induced FXII ai DTT of pooled normal plasma prolonged, and addition of FXI to FXI deficient plasma shortened FXII ai DTT. (3) Alpha-thrombin blocked by hirudin at different time (10 - 80 seconds) resulted in decreased FXa generation, and the earlier the block, the more the decrease. Under the same condition, the amount of FXa generation was in order of platelet-rich plasma > platelet-poor plasma > FXI deficient plasma.


CONCLUSIONS
(1) Our data support the two-stage hypothesis and confirm the important role of FXI in the amplification stage. (2) FXII ai DTT as a screening test for coagulation process may be practicable.
He
S
S
Department of Hemostatic Physiology, Hunan Medical University, Changsha 410078, China.
Xiong
S
S
He
R
R
He
X
X
Liu
F
F
Han
J
J
Li
J
J
D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000502:physiology; D005172:Factor XI / Q000502:physiology; D015956:Factor XIIa / Q000037:antagonists & inhibitors*; D006801:Humans; D013925:Thromboplastin / Q000378:metabolism*
D005172:Factor XI; D013925:Thromboplastin; D015956:Factor XIIa